Article Details

Lilly Announces Head-to-Head Study Comparing Once-Monthly Emgality® with Every-Other-Day ...

Retrieved on: 2021-06-15 10:41:15

Tags for this article:

Click the tags to see associated articles and topics

Lilly Announces Head-to-Head Study Comparing Once-Monthly Emgality® with Every-Other-Day .... View article details on hiswai:

Excerpt

Emgality is a monoclonal antibody that selectively binds to calcitonin gene-related peptide (CGRP) and was approved by the FDA in September 2018 for ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo